In a post on X, Mr Goenka highlighted how the growing use of these medicines could create new business opportunities while putting pressure on industries that depend on food consumption and changing lifestyle habits. The growing popularity of GLP-1 weight-loss drugs could bring major changes to businesses across the world, affecting everything from food and beverages to healthcare, fitness and travel, according to industrialist Harsh Goenka.
The apparel sector could also see changes in consumer demand, with shifting body sizes potentially influencing clothing preferences, fashion trends and the demand for different sizes. Interestingly, Mr Goenka also pointed to the travel and aviation sectors as potential beneficiaries. Lower average passenger weight could, in theory, help airlines reduce fuel consumption and operating costs, although the actual impact would depend on several factors. Packaged food companies, particularly those selling snacks, confectionery and calorie-dense products, may need to rethink their offerings. Fast-food chains and restaurants could also face pressure if consumers begin choosing smaller portions or eating out less frequently. Food delivery platforms could be affected too, especially if customers order fewer indulgent meals.
